Overview

This trial is active, not recruiting.

Condition interstitial lung diseases
Sponsor St. Antonius Hospital
Start date January 2006
Trial size 100000 participants
Trial identifier NCT00267800, R05.08/A

Summary

The cause of most interstitial lung diseases (ILDs) is still unknown. Further research, for example to determine predisposing genetic factors, is therefore needed. A database with relevant clinical data and DNA/serum samples of ILD patients could facilitate future research on the cause of ILDs.

United States No locations recruiting
Other Countries No locations recruiting

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Diagnosis of an ILD, as stated by the American Thoracic Society (ATS)

Additional Information

Official title Registration of Clinical Data and DNA/Serum of Patients With Interstitial Lung Diseases (ILD)
Principal investigator J.M.M. van den Bosch, M.D.
Description Protocol title: 'Registration of clinical data and DNA of patients with Interstitial Lung Disease (ILD)' Rationale: The etiopathogenesis of most Interstitial Lung Diseases (ILDs) is still unknown. Further research, e.g. to determine predisposing genetic factors, is therefore needed. A database with relevant clinical data and DNA/serum samples of ILD patients could facilitate future research on the etiopathogenesis of ILDs. Objective: Availability of relevant clinical data and DNA/serum samples of ILD patients in a database. Those data can be used for future research. Study design: A prospective observational study Study population: Patients diagnosed with ILD attending the pulmonology department in participating hospitals. Intervention: a blood sample is taken from each patient. Furthermore, additional information is collected from the medical file. Main study parameters/endpoints: DNA and serum sample, demographic variables, medical information, occupational history and hobbies. Nature and extent of the burden and risks associated with participation, group relatedness: two tubes of blood will be drawn from the patients. The risks of drawing blood from a vein are minimal.
Trial information was received from ClinicalTrials.gov and was last updated in August 2008.
Information provided to ClinicalTrials.gov by St. Antonius Hospital.